Volume 100, Issue 7

Search all Annals of Hematology articles

July 2021

32 articles in this issue

Thrombocytosis in children and adolescents—classification, diagnostic approach, and clinical management
Clemens Stockklausner
C. M. Duffert
On behalf of THROMKID-Plus Studiengruppe der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) and of Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH)
Review Article Open access 12 March 2021 Pages: 1647 - 1665
Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience
Deniz Goren Sahin
Olga Meltem Akay
Fevzi Altuntas
Original Article 14 May 2021 Pages: 1667 - 1675
The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review
Linet Njue
Cesare Medri
Alicia Rovó
Original Article Open access 15 February 2021 Pages: 1677 - 1683
Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
Petro E. Petrides
Michael Klein
Maria K. Beykirch
Original Article Open access 29 May 2021 Pages: 1685 - 1693
Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis
Manisha Gadgeel
Batool AlQanber
Süreyya Savaşan
Original Article 23 April 2021 Pages: 1695 - 1700
Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients
Doaa I. Elzaeem
Esmat A. El Sharkawi
Waleed M. Abd El-Hamed
Original Article 13 May 2021 Pages: 1701 - 1709
Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome
Dolores Subirá
Canan Alhan
Dunia de Miguel
Original Article 09 January 2021 Pages: 1711 - 1722
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry
Timothy Devos
Violaine Havelange
Dominik Selleslag
Original Article Open access 04 May 2021 Pages: 1723 - 1732
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
Richard Greil
Alessandra Tedeschi
Fatih Demirkan
Original Article Open access 20 May 2021 Pages: 1733 - 1742
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study
Salvatore Leotta
Uros Markovic
Giuseppe Milone
Original Article 28 March 2021 Pages: 1743 - 1753
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
Ryszard Swoboda
Sebastian Giebel
Jan Maciej Zaucha
Original Article Open access 24 February 2021 Pages: 1755 - 1767
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
María José Cejalvo
Gabriela Bustamante
Javier de la Rubia
Original Article 22 April 2021 Pages: 1769 - 1778
Characteristics and survival trends in Finnish multiple myeloma patients—a nationwide real-world evidence study
Iiro Toppila
Tatu Miettinen
Pekka Anttila
Original Article 12 March 2021 Pages: 1779 - 1787
Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience
Zi-Liang Hou
Yu Kang
Huan-Zhong Shi
Original Article 14 March 2021 Pages: 1789 - 1801
Oral therapy adherence and satisfaction in patients with multiple myeloma
Marine Solano
Etienne Daguindau
Anne-Laure Clairet
Original Article 03 May 2021 Pages: 1803 - 1813
A novel Twist1/hsa-miR138-5p/caspase-3 pathway regulates cell proliferation and apoptosis of human multiple myeloma
Wenjiao Qin
Qin Liu
Tao Zhang
Original Article 09 May 2020 Pages: 1815 - 1824
Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS)
Cyrille Touzeau
Nadia Quignot
Gaëlle Désaméricq
Original Article Open access 21 April 2021 Pages: 1825 - 1836
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience
Sara Butera
Marco Cerrano
Luisa Giaccone
Original Article Open access 04 May 2021 Pages: 1837 - 1847
Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan
Masamichi Isobe
Takaaki Konuma
for the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
Original Article 23 February 2021 Pages: 1849 - 1861
Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies
Christian A. Gordillo
Sapna Parmar
Ran Reshef
Original Article 03 January 2021 Pages: 1863 - 1870
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
Linus Angenendt
Isabel Hilgefort
Christoph Schliemann
Original Article Open access 19 December 2020 Pages: 1871 - 1878
The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimen
Peng Ke
Xinyou Zhang
Xiebing Bao
Original Article 22 April 2021 Pages: 1879 - 1889
Complete regression of an HCV-associated diffuse large B cell lymphoma achieved by chemoimmuno-free antiviral therapy
Xiao-Hong Sun
Li-Na Wang
Ya-Ming Xi
Letter to the Editor 06 January 2021 Pages: 1891 - 1894
HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient
Margarete Voigt
Konrad Sinn
Ulf Schnetzke
Letter to the Editor Open access 14 January 2021 Pages: 1895 - 1897
Chronic active Epstein-Barr virus infection of T cell type presenting with hemophagocytic lymphohistiocytosis in a Caucasian adult
Debbie Jiang
Zhao Ming Dong
Nicholas Burwick
Letter to the Editor 06 February 2021 Pages: 1899 - 1900
A belated diagnosis of G6PD deficiency in an 81-year-old woman
Violaine Tran Quang
Sihem Tarfi
Orianne Wagner-Ballon
Letter to the Editor 27 January 2021 Pages: 1901 - 1902
Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia
Khaled M. Musallam
Maria Domenica Cappellini
Ali T. Taher
Letter to the Editor 11 February 2021 Pages: 1903 - 1905
Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity
Paolo Ricchi
Silvia Costantini
Aldo Filosa
Letter to the Editor 13 April 2021 Pages: 1907 - 1910
Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?
Keisuke Kidoguchi
Yasutaka Kuniyoshi
Yuki Kataoka
Letter to the Editor 12 April 2021 Pages: 1911 - 1912
Incidence and impact of Epstein-Barr virus events in the early phase after allogeneic hematopoietic cell transplantation
Samuel Macy
Jakob Passweg
Michael Medinger
Letter to the Editor 03 June 2021 Pages: 1913 - 1915
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Michael Heuser
B. Douglas Smith
Jorge E. Cortes
Correction Open access 12 May 2021 Pages: 1917 - 1918
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
Ryszard Swoboda
Sebastian Giebel
Jan Maciej Zaucha
Correction Open access 24 March 2021 Pages: 1919 - 1919

Volume 100, Issue 7

Thrombocytosis in children and adolescents—classification, diagnostic approach, and clinical management

Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience

The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review

Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients

Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry

Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study

The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study

High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma

Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma

Characteristics and survival trends in Finnish multiple myeloma patients—a nationwide real-world evidence study

Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience

Oral therapy adherence and satisfaction in patients with multiple myeloma

A novel Twist1/hsa-miR138-5p/caspase-3 pathway regulates cell proliferation and apoptosis of human multiple myeloma

Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS)

Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience

Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan

Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies

Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimen

Complete regression of an HCV-associated diffuse large B cell lymphoma achieved by chemoimmuno-free antiviral therapy

HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient

Chronic active Epstein-Barr virus infection of T cell type presenting with hemophagocytic lymphohistiocytosis in a Caucasian adult

A belated diagnosis of G6PD deficiency in an 81-year-old woman

Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia

Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity

Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?

Incidence and impact of Epstein-Barr virus events in the early phase after allogeneic hematopoietic cell transplantation

Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma

Navigation